TY - JOUR
T1 - Structural and functional effects of myosin binding protein-C phosphorylation in heart muscle are not mimicked by serine-to-aspartate substitutions
AU - Kampourakis, Thomas
AU - Ponnam, Saraswathi
AU - Sun, Yin-Biao
AU - Sevrieva, Ivanka Radkova
AU - Irving, Malcolm
PY - 2018/8/6
Y1 - 2018/8/6
N2 - Myosin-binding protein-C (cMyBP-C) is a key regulator of contractility in heart muscle, and its regulatory function is controlled in turn by phosphorylation of multiple serines in its m-domain. The structural and functional effects of m-domain phosphorylation have often been inferred from those of the corresponding serine-to-aspartate (S–D) substitutions, in both in vivo and in vitro studies. Here, using a combination of in vitro binding assays and in situ structural and functional assays in ventricular trabeculae of rat heart and the expressed C1mC2 region of cMyBP-C, containing the m-domain flanked by domains C1 and C2, we tested whether these substitutions do in fact mimic the effects of phosphorylation. In situ changes in thin and thick filament structure were determined from changes in polarized fluorescence from bifunctional probes attached to troponin C or myosin regulatory light chain, respectively. We show that both the action of exogenous C1mC2 to activate contraction in the absence of calcium and the accompanying change in thin filament structure are abolished by tris-phosphorylation of the m-domain, but unaffected by the corresponding S–D substitutions. The latter produced an intermediate change in thick filament structure. Both tris-phosphorylation and S–D substitutions abolished the interaction between C1mC2 and myosin sub-fragment 2 (myosin S2) in vitro, but yielded different effects on thin filament binding. These results suggest that some previous inferences from the effects of S–D substitutions in cMyBP-C should be reconsidered and that the distinct effects of tris-phosphorylation and S–D substitutions on cMyBP-C may provide a useful basis for future studies.
AB - Myosin-binding protein-C (cMyBP-C) is a key regulator of contractility in heart muscle, and its regulatory function is controlled in turn by phosphorylation of multiple serines in its m-domain. The structural and functional effects of m-domain phosphorylation have often been inferred from those of the corresponding serine-to-aspartate (S–D) substitutions, in both in vivo and in vitro studies. Here, using a combination of in vitro binding assays and in situ structural and functional assays in ventricular trabeculae of rat heart and the expressed C1mC2 region of cMyBP-C, containing the m-domain flanked by domains C1 and C2, we tested whether these substitutions do in fact mimic the effects of phosphorylation. In situ changes in thin and thick filament structure were determined from changes in polarized fluorescence from bifunctional probes attached to troponin C or myosin regulatory light chain, respectively. We show that both the action of exogenous C1mC2 to activate contraction in the absence of calcium and the accompanying change in thin filament structure are abolished by tris-phosphorylation of the m-domain, but unaffected by the corresponding S–D substitutions. The latter produced an intermediate change in thick filament structure. Both tris-phosphorylation and S–D substitutions abolished the interaction between C1mC2 and myosin sub-fragment 2 (myosin S2) in vitro, but yielded different effects on thin filament binding. These results suggest that some previous inferences from the effects of S–D substitutions in cMyBP-C should be reconsidered and that the distinct effects of tris-phosphorylation and S–D substitutions on cMyBP-C may provide a useful basis for future studies.
U2 - 10.1074/jbc.AC118.004816
DO - 10.1074/jbc.AC118.004816
M3 - Letter
SN - 0021-9258
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
ER -